253 related articles for article (PubMed ID: 27792814)
1. Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.
Ekanayaka SA; McClellan SA; Barrett RP; Kharotia S; Hazlett LD
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5799-5809. PubMed ID: 27792814
[TBL] [Abstract][Full Text] [Related]
2. Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
Ekanayaka SA; McClellan SA; Barrett RP; Hazlett LD
J Ocul Pharmacol Ther; 2018 Apr; 34(3):239-249. PubMed ID: 29236588
[TBL] [Abstract][Full Text] [Related]
3. Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.
McClellan SA; Ekanayaka SA; Li C; Jiang X; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8091-100. PubMed ID: 26720461
[TBL] [Abstract][Full Text] [Related]
4. HGF signaling impacts severity of Pseudomonas aeruginosa keratitis.
Jiang X; McClellan SA; Barrett R; Foldenauer M; Hazlett LD
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2180-90. PubMed ID: 24618323
[TBL] [Abstract][Full Text] [Related]
5. NLRP12 promotes host resistance against Pseudomonas aeruginosa keratitis inflammatory responses through the negative regulation of NF-κB signaling.
Deng QC; Deng CT; Li WS; Shu SW; Zhou MR; Kuang WB
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8063-8075. PubMed ID: 30556841
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.
Li C; McClellan SA; Barrett R; Hazlett LD
Invest Ophthalmol Vis Sci; 2014 Oct; 55(10):6886-900. PubMed ID: 25298414
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.
McClellan S; Jiang X; Barrett R; Hazlett LD
J Immunol; 2015 Feb; 194(4):1776-87. PubMed ID: 25589066
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 Antagonist, Box A, Reduces TLR4, RAGE, and Inflammatory Cytokines in the Cornea of P. aeruginosa-Infected Mice.
Ekanayaka SA; McClellan SA; Peng X; Barrett RP; Francis R; Hazlett LD
J Ocul Pharmacol Ther; 2018 Nov; 34(10):659-69. PubMed ID: 30407111
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies.
Hazlett LD; Ekanayaka SA; McClellan SA; Francis R
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2978-2989. PubMed ID: 31311033
[TBL] [Abstract][Full Text] [Related]
10. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
11. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
Huang X; Du W; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
[TBL] [Abstract][Full Text] [Related]
12. Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis.
Berger EA; Vistisen KS; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7432-9. PubMed ID: 23036997
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
[TBL] [Abstract][Full Text] [Related]
14. The role of VIP in cornea.
Jiang X; McClellan SA; Barrett RP; Zhang Y; Foldenauer ME; Hazlett LD
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7560-6. PubMed ID: 23074208
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains.
Carion TW; McWhirter CR; Grewal DK; Berger EA
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6932-40. PubMed ID: 26513498
[TBL] [Abstract][Full Text] [Related]
16. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
17. Ocular Effects of Glycyrrhizin at Acidic and Neutral pH.
Somayajulu M; McClellan SA; Bessert DA; Pitchaikannu A; Hazlett LD
Front Cell Infect Microbiol; 2021; 11():782063. PubMed ID: 35127554
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin Interacts with TLR4 and TLR9 to Resolve
Somayajulu M; McClellan SA; Farooq SM; Pitchaikannu A; Xu S; Hazlett L
Pathogens; 2022 Nov; 11(11):. PubMed ID: 36422579
[TBL] [Abstract][Full Text] [Related]
19. Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis.
Chen K; Wu Y; Zhu M; Deng Q; Nie X; Li M; Wu M; Huang X
Mol Vis; 2013; 19():1502-14. PubMed ID: 23878501
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Knockdown of the miR-183/96/182 Cluster Ameliorates Pseudomonas aeruginosa-Induced Keratitis.
McClellan S; Pitchaikannu A; Wright R; Bessert D; Iulianelli M; Hazlett LD; Xu S
Invest Ophthalmol Vis Sci; 2021 Dec; 62(15):14. PubMed ID: 34919120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
